News

Baby’s life was at risk due to a serious chest infection but expert care and extracorporeal membrane oxygenation helped him ...
The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...
A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private sector, but not yet in public clinics. The country’s advisory group on ...
Each year in the UK, 30,000 children under the age of five are hospitalised with RSV and it causes around 30 infant deaths.
The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV, ...
As the U.S. approaches the midpoint of summer, the CDC is reporting cases of the virus are growing or likely growing in dozens of states.
The largest US real-world study of BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection successfully met both of its co-primary endpoints, demonstrating that BEYFORTUS provides protection for babies ...
John Stewart, Director of Specialised Commissioning at NHS England said: “For babies born very prematurely, the risk of ...
The COVID booster currently available is based on the JN.1 subvariant. Nimbus is a direct descendant of JN.1 – as is another ...
STAFF WRITERS GIPPSLANDERS are being urged to protect themselves and their loved ones against flu and respiratory syncytial ...
In addition to new backpacks, school supplies and books, the return to class also increases the risk of bacteria being spread ...
A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of newborns with severe lung infections. By passing virus-fighting antibodies to ...